These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6764078)

  • 1. Chronic cholestatic hepatitis-primary biliary cirrhosis. Biochemical and immunologic parameters.
    Tapalaga D; Dumitrascu D; Grigorescu M; Suciu A
    Acta Gastroenterol Belg; 1982; 45(9-10):386-91. PubMed ID: 6764078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemic cholestatic hepatitis with severe hyperlipemia].
    Alcindor LG; Infante R; Vanhove A; Levy VG; Ammar AB; Léo M; Caroli J
    Ann Med Interne (Paris); 1972 Nov; 123(11):951-60. PubMed ID: 4659558
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ineffectiveness of corticosteroids in cholestatic forms of chronic active hepatitis].
    Degos F; Degott C; Erlinger S
    Gastroenterol Clin Biol; 1980 Apr; 4(4):246-50. PubMed ID: 7188271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of pediatric systemic polyarteritis nodosa with cholestatic hepatitis.
    Park HJ; Choi YJ; Kim JE; Ye YM; Park HS; Suh CH
    Clin Rheumatol; 2007 Jan; 26(1):122-4. PubMed ID: 16362446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.
    Baker AL; Krager PS; Kotake AN; Schoeller DA
    Hepatology; 1987; 7(3):464-7. PubMed ID: 3570158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of the serum electrolytes sodium and potassium in patients with cholelithiasis with reference to pathologic changes in the liver].
    Schmauss AK; Gerloff D; Poley FW
    Z Gesamte Inn Med; 1971 May; 26(10):327-31. PubMed ID: 5131401
    [No Abstract]   [Full Text] [Related]  

  • 7. Spectrum of hepatic manifestations of granulomatous hepatitis of unknown etiology.
    Mir-Madjlessi SH; Farmer RG; Hawk WA
    Am J Gastroenterol; 1974 Sep; 62(3):221-9. PubMed ID: 4424950
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum alpha 1-acid glycoprotein in chronic ulcerative colitis.
    Dearing WH; McGuckin WF; Elveback LR
    Gastroenterology; 1969 Feb; 56(2):295-303. PubMed ID: 5764596
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis and cholestasis in a middle-aged woman.
    Perrillo RP; Mason AL; Jacob S; Gerber MA
    Hepatology; 1996 Sep; 24(3):730-4. PubMed ID: 8781350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of the clinical course of primary biliary liver cirrhosis].
    Loginov AS; Iartseva AM; Kriukova LV; Kutchak SN
    Ter Arkh; 1976; 48(9):12-20. PubMed ID: 996757
    [No Abstract]   [Full Text] [Related]  

  • 11. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo.
    Tacke F; Wüstefeld T; Horn R; Luedde T; Srinivas Rao A; Manns MP; Trautwein C; Brabant G
    J Hepatol; 2005 May; 42(5):666-73. PubMed ID: 15826715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of determining bile acids in the blood of patients with chronic cholestatic hepatitis and primary biliary cirrhosis].
    Radchenko VG; Mekhanik ZI
    Vrach Delo; 1985 May; (5):26-8. PubMed ID: 4013219
    [No Abstract]   [Full Text] [Related]  

  • 13. [SP1 serum levels during cholestatic hepatosis and chronic hepatitis].
    Fuchs V; Fialová L; Malbohan I
    Cesk Gynekol; 1985 Aug; 50(7):472-8. PubMed ID: 3876166
    [No Abstract]   [Full Text] [Related]  

  • 14. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease.
    Long RG; Skinner RK; Wills MR; Sherlock S
    Lancet; 1976 Sep; 2(7987):650-2. PubMed ID: 60515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conjugated serum bile acids in chronic liver diseases and cholestasis].
    Frosch B; Wagener H
    Acta Hepatosplenol; 1971; 18(4):273-86. PubMed ID: 5110093
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive therapy of chronic aggressive hepatitis].
    Maleev A; Stojanov S
    Z Gesamte Inn Med; 1973 Oct; 28(20):Suppl:307-9. PubMed ID: 4767201
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recurrent cholestatic course of chronic aggressive hepatitis].
    Erb W; Siede W
    Dtsch Med Wochenschr; 1969 May; 94(22):1145-50. PubMed ID: 5768539
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcome of chronic cholestatic lesions of the liver (mechanisms of development of biliary liver cirrhosis)].
    Bliuger AF; Maksimova LA; Kartashova OIa; Briedis LP
    Ter Arkh; 1976; 48(9):20-4. PubMed ID: 996761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.